ENZN
Price
$0.11
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
8.53M
ERNA
Price
$2.00
Change
+$0.02 (+1.01%)
Updated
Jul 3 closing price
Capitalization
14.72M
Interact to see
Advertisement

ENZN vs ERNA

Header iconENZN vs ERNA Comparison
Open Charts ENZN vs ERNABanner chart's image
Enzon Pharmaceuticals
Price$0.11
Change-$0.00 (-0.00%)
Volume$18.23K
Capitalization8.53M
Ernexa Therapeutics
Price$2.00
Change+$0.02 (+1.01%)
Volume$29.43K
Capitalization14.72M
ENZN vs ERNA Comparison Chart in %
Loading...
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENZN vs. ERNA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENZN is a Hold and ERNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ENZN: $0.11 vs. ERNA: $2.00)
Brand notoriety: ENZN and ERNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENZN: 34% vs. ERNA: 45%
Market capitalization -- ENZN: $8.53M vs. ERNA: $14.72M
ENZN [@Biotechnology] is valued at $8.53M. ERNA’s [@Biotechnology] market capitalization is $14.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENZN’s FA Score shows that 1 FA rating(s) are green whileERNA’s FA Score has 0 green FA rating(s).

  • ENZN’s FA Score: 1 green, 4 red.
  • ERNA’s FA Score: 0 green, 5 red.
According to our system of comparison, ENZN is a better buy in the long-term than ERNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENZN’s TA Score shows that 6 TA indicator(s) are bullish while ERNA’s TA Score has 4 bullish TA indicator(s).

  • ENZN’s TA Score: 6 bullish, 4 bearish.
  • ERNA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ENZN is a better buy in the short-term than ERNA.

Price Growth

ENZN (@Biotechnology) experienced а +14.90% price change this week, while ERNA (@Biotechnology) price change was +5.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERNA($14.7M) has a higher market cap than ENZN($8.53M). ENZN YTD gains are higher at: -26.393 vs. ERNA (-54.649). ENZN has more cash in the bank: 45M vs. ERNA (1.92M). ERNA has less debt than ENZN: ERNA (2.88M) vs ENZN (116M).
ENZNERNAENZN / ERNA
Capitalization8.53M14.7M58%
EBITDA-2MN/A-
Gain YTD-26.393-54.64948%
P/E Ratio96.10N/A-
Revenue26KN/A-
Total Cash45M1.92M2,346%
Total Debt116M2.88M4,025%
FUNDAMENTALS RATINGS
ENZN vs ERNA: Fundamental Ratings
ENZN
ERNA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5195
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ERNA's Valuation (60) in the Medical Specialties industry is in the same range as ENZN (85) in the Biotechnology industry. This means that ERNA’s stock grew similarly to ENZN’s over the last 12 months.

ERNA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ENZN (100) in the Biotechnology industry. This means that ERNA’s stock grew similarly to ENZN’s over the last 12 months.

ENZN's SMR Rating (97) in the Biotechnology industry is in the same range as ERNA (100) in the Medical Specialties industry. This means that ENZN’s stock grew similarly to ERNA’s over the last 12 months.

ENZN's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for ERNA (95) in the Medical Specialties industry. This means that ENZN’s stock grew somewhat faster than ERNA’s over the last 12 months.

ENZN's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for ERNA (100) in the Medical Specialties industry. This means that ENZN’s stock grew significantly faster than ERNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENZNERNA
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PILBF1.010.09
+9.60%
PILBARA MINERALS LTD
SGPTF0.220.01
+3.63%
SAGE POTASH CORP
JGCCF8.50N/A
N/A
JGC Holdings Corporation
NWPHF9.36N/A
N/A
Newron Pharmaceuticals SPA
FIDS21.00N/A
N/A
FNB, Inc.

ENZN and

Correlation & Price change

A.I.dvisor tells us that ENZN and CLDX have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENZN and CLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENZN
1D Price
Change %
ENZN100%
+1.95%
CLDX - ENZN
8%
Poorly correlated
-0.50%
HALO - ENZN
2%
Poorly correlated
+0.30%
INCY - ENZN
2%
Poorly correlated
+0.41%
EXEL - ENZN
2%
Poorly correlated
+4.18%
ERNA - ENZN
-4%
Poorly correlated
+1.01%
More

ERNA and

Correlation & Price change

A.I.dvisor tells us that ERNA and ATOS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERNA and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERNA
1D Price
Change %
ERNA100%
+1.01%
ATOS - ERNA
28%
Poorly correlated
+1.43%
RNTX - ERNA
27%
Poorly correlated
-1.95%
VSTM - ERNA
25%
Poorly correlated
-1.03%
RAIN - ERNA
25%
Poorly correlated
+2.30%
NMRA - ERNA
25%
Poorly correlated
+5.04%
More